Max Healthcare Institute Limited has informed the Exchange about approval of Scheme of Amalgamation between Crosslay Remedies Limited and Jaypee Healthcare Limited
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Max Healthcare has informed the exchange that the Scheme of Amalgamation between Crosslay Remedies Limited and Jaypee Healthcare Limited has been approved. Both Crosslay Remedies and Jaypee Healthcare are part of the Max Healthcare group and operate hospital businesses. The merger is an internal consolidation aimed at simplifying the group's corporate structure. No share swap ratio, financial consideration, or timeline details were disclosed in this filing. Shareholders will need to watch for further updates on the effective date and any related disclosures.
This is an internal group restructuring with no direct financial impact on Max Healthcare shareholders. In the long term, it may bring operational efficiencies by reducing the number of group entities.